GenomOncology, a Cleveland company that has developed a technology platform to streamline the use of next-generation sequencing data in medical care and research, said it has named Dr. Joshua F. Coleman as vice president of medical affairs.
GenomOncology, a Cleveland company that has developed a technology platform to streamline the use of next-generation sequencing data in medical care and research, said it has named Dr. Joshua F. Coleman as vice president of medical affairs.